Medically supervised programme

Lose weight
with science and a doctor's plan

A medically supervised weight-management programme — video consultations with an endocrinologist and treatment, including medication therapy if the doctor prescribes it.

Supported by
Novo Nordiskmanssvars.lv

The programme is authored by Medon. The face scanner is provided by ComeStai with the support of Novo Nordisk.

Weight calculator
Your weight today
95kg

60 kg

180 kg

Average loss
−20kg
−21% of body weight
New weight
75kg
after 72 weeks (~17 months)
Check your eligibility

Based on the STEP UP clinical trial (semaglutide 7.2 mg, Lancet Diabetes & Endocrinology 2025) — the average result in adults with a BMI ≥30 after 72 weeks when the therapy is taken as intended. In the trial, weight changes were observed as early as week 4. Individual results may vary. This is not a medical recommendation.

The science

What is GLP-1?

GLP-1 is a satiety hormone the body produces after eating. The therapy amplifies its effect — less appetite, smaller portions, a steadier weight. A doctor assesses both eligibility and dose.

It is not a miracle drug — the therapy works under a doctor's supervision, alongside changes in diet and movement. That is why the doctor reviews your everyday habits at every visit, not just the dose.

GLP-1 is not meant for everyone. It treats medical obesity; it is not a shortcut for losing a few kilograms — if you don't meet the criteria, the doctor will not prescribe it. A great deal can be achieved through diet and lifestyle changes, and Medon specialists can help with that too.

~21%
Average weight loss
72wks
Length of the clinical trial
1407pts
Participants in the trial

Source: Wharton S et al., Lancet Diabetes & Endocrinology 2025 (STEP UP, semaglutide 7.2 mg) — the average result when the therapy is taken as intended. With the 2.4 mg dose in the same trial — −17.5%.

The foundation

Results are built on lifestyle

Whether or not the doctor prescribes therapy, the programme rests on lifestyle changes — they are what decides how durable the result is once the programme ends.

Nutrition

Realistic changes to everyday eating, not strict diets

Movement

Activity that fits your day — no obligatory gym membership

Sleep and stress

Habits that quietly shape weight and appetite

Medication therapy

Only after a doctor's decision — support for the rest, not a substitute

"Weight loss is a process that needs an individual approach and a doctor's supervision. The programme lets a patient receive a medically grounded assessment and choose the safest route to a result together with a specialist."
Sabīne Upmale-Engela
Sabīne Upmale-EngelaEndocrinologist, methodological lead of the programme
The programme

Five steps to losing weight

01

Eligibility check

A 2-minute BMI check, no registration. If you qualify, you get a support code and the recommended lab-test list before your visit.

02

Endocrinologist consultation

A video consultation (30 min) — the doctor reviews your health, lab results and medical history.

03

Decision and plan

If the therapy suits you, the doctor writes a prescription. Either way you receive an individual plan for the next steps.

04

Receiving the medication

If the doctor writes a prescription, buy the medication at any pharmacy. With BENU Aptieka delivery you can have it brought to your home.

05

Follow-up visits

Regular monitoring — weight changes, dose adjustment, side effects and an updated plan.

Eligibility

Is the programme right for you?

A two-minute check: BMI ≥30, or ≥27 with a weight-related condition. If you qualify, you immediately receive the support programme code (50% off) for the first consultation and the recommended lab-test list.

Start the eligibility check

No registration · the final decision is the doctor's

Still unsure?

Start with 40 seconds

The free face scanner uses your phone camera to assess heart rate, breathing and stress level — and shows what is worth discussing with a doctor. No commitment, no cost.

  1. 1Register or sign in — the results land in your account
  2. 2Scan your face with the phone camera for 40 seconds
  3. 3Get your wellbeing picture and, if you want, discuss the results with a doctor
Try it for free

The scanner is not a medical device. The results are estimates from camera-signal analysis and do not replace a doctor's assessment. · Your data is protected, and the results are stored securely in your Medon account

Example of the scanner results page
Safety

Honestly about side effects

GLP-1 is not suitable for everyone. Before writing a prescription, the doctor checks your health status and any contraindications.

Most common side effects

In the first weeks and while increasing the dose; usually subside

  • Nausea and vomiting
  • Constipation or diarrhoea
  • Headaches and fatigue
  • Reduced appetite

When the therapy is not suitable

The list is not exhaustive — individual suitability is assessed by the doctor

  • Pregnancy, planning one in the coming months, or breastfeeding
  • Hypersensitivity to the active substance
  • A history of pancreatitis — requires particular assessment
  • Medullary thyroid cancer personally or in the family, MEN 2 syndrome
Costs

Transparent about costs

The programme has three cost components to plan for. No hidden fees, no long-term contract — you pay only for what you use.

Initial consultation
64*

€32 with Novo Nordisk support (-50%)

  • Endocrinologist · 30 min
  • Review of BMI, lab results and medical history
  • Decision on eligibility
  • An individual plan for the next steps
Book a consultation
Medication therapy
145–195**

approximate price per month — paid at the pharmacy, depending on the therapy and dose

  • Only after a doctor's decision and prescription
  • Buy the medication at a pharmacy with an e-prescription
  • BENU Aptieka offers home delivery
  • Usage materials and support
Follow-up visits
54*

every 1–3 months while the dose is adjusted, later roughly every six months

  • Video consultation with an endocrinologist
  • Dose adjustment
  • Managing side effects
  • An updated plan for the next steps

* In many health insurance policies weight-management consultations are an exclusion — check your policy's cover or ask your insurer before submitting an invoice. To claim reimbursement under your health insurance policy, submit to the insurer the invoice you receive after the consultation together with the payment order from your online bank.

** The price range corresponds to the therapy doses registered in Latvia. The choice of a specific prescription medicine and dose is solely the doctor's competence — according to indications, contraindications and availability. This page does not advertise specific medicines and does not replace a doctor's consultation. Prices are indicative, based on publicly available manufacturer price lists and the Latvian Medicines Register; the final price is set by the pharmacy.

The team

You'll be supervised by certified specialists

The programme is delivered by certified endocrinologists — you get your own doctor, responsible for your progress throughout the programme. If you wish, you can additionally book a Medon dietitian.

Questions patients ask

That is a real risk — within one year of stopping the medication people regain on average two-thirds of the weight lost, if durable diet and lifestyle habits were not built alongside it. That is why the doctor reviews your everyday habits at every follow-up visit — so the result holds after the therapy too.
Therapy starts at a low dose that is gradually increased to the maintenance dose over roughly 16 weeks — which reduces side effects. In the STEP UP trial the therapy lasted 72 weeks. The duration of treatment is set by the doctor individually, based on your progress and how well you tolerate the medication.
GLP-1 receptor agonists are a class of prescription medicines with different active substances (e.g. semaglutide, liraglutide) and different registered indications — one for treating type 2 diabetes, another for weight loss. Doses, frequency of use and effect differ. The specific medicine is chosen by the doctor based on your health status and indications — we do not advertise a particular brand.
At present, using GLP-1 for weight loss (a non-diabetes indication) is not state-funded in Latvia. Health insurance usually does not cover the cost of the medication either, but do check this with your insurer. Some policies may cover the consultation part, though many list weight-management consultations among their exclusions, so confirm your policy's cover before submitting an invoice. To claim reimbursement, submit to the insurer the invoice you receive after each Medon consultation together with the payment order from your online bank.
The State Agency of Medicines (ZVA) and the Health Inspectorate remind that medicines may be bought online only from licensed online pharmacies — selling medicines through social media ads or dubious websites is prohibited. Medicines bought that way may be counterfeit: with an altered composition or a different active substance than stated, posing a serious health risk. Through the Medon programme the medication is prescribed by a doctor registered in Latvia and dispensed by a licensed pharmacy.
No. GLP-1 is contraindicated during pregnancy and breastfeeding. If you are planning a pregnancy, the medication must be stopped at least 2 months beforehand.

Let's start with a consultation

One visit — no subscription or contract. The doctor will assess your eligibility, and the decision on next steps is yours.

Book a consultation

Supported by Novo Nordisk · manssvars.lv